Sponsor Pipeline

Chongqing Claruvis Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Phase 3
Active Trials by Phase
Phase 3
1
Phase 2/3
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07478822 A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple… Upper Limb Spasticity Recruiting
Phase 2/3
NCT06783114 A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The… Upper Limb Spasticity Recruiting
Get alerts when Chongqing Claruvis Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free